Regulation of Breast Cancer Cell Proliferation and Immunity via Targeting Autophagic Process Using siRNA Antagonist Atg-5 in MCF-7 Cells.

Targeting autophagy in breast cancer

  • Amira Alian Department of Molecular Biology, Genetic Engineering and Biotechnology Research Institute, University of Sadat City, Sadat City, Egypt
  • Adel A. Guirgis Department of Molecular Biology, Genetic Engineering and Biotechnology Research Institute, University of Sadat City, Sadat City, Egypt.
  • Hany Khalil Department of Molecular Biology, Genetic Engineering and Biotechnology Research Institute, University of Sadat City
Keywords: Breast cancer, Autophagy, RNAi, Cytokine

Abstract

Background: Breast cancer initiates when normal breast epithelial cells begin to replicate unusually. These cells divide more rapidly than normal cells and continue to be accumulated and formed a lump or mass. Cells may migrate (metastasis stage) from breast tissues to lymph nodes or other human body parts. Cellular autophagy is one of the most critical mechanisms in breast cancer development. Autophagy plays a dual function as a tumor support process or suppressor mechanism. Accordingly, we aimed to highlight the molecular role of autophagy in breast cancer development and cancer therapy using RNA interference (RNAi). 

Material and Methods: MCF-7 cell line was used to investigate the direct connection between breast cancer and the autophagy pathway using a respective siRNA antagonist, Atg-5

Results: MCF-7 cell morphology was markedly influenced by transfection with siRNA antagonist Atg-5 compared with control-transfected and untreated cells. Likewise, the number of liPleving MCF-7 cells reduced in transfected cells with siRNA that antagonist ATG-5, while the relative lactate dehydrogenates (LDH) production significantly increased compared with control-transfected cells. Notably, the knockdown efficiency of Atg-5 gene expression was almost 60% inhibition when the MCF-7 was transfected with the siRNA antagonist Atg-5. Furthermore, the relative gene expression of interleukin -8 (IL-8) and transforming growth factor-beta (TGF-β) downregulated in response to depleted Atg-5 in transfected cells. 

Conclusion: Our findings demonstrate that downregulation of Atg-5 leads to sufficient disturbance of autophagic machinery and subsequently regulates breast cancer cell proliferation.  

References

Li Z, Wei H, Li S, et al. The Role of Progesterone Receptors in Breast Cancer. Drug Des Devel Ther, 2022, 16:305–314. https://doi.org/10.2147/DDDT.S336643

Khalil H, Abd ElHady A, Elawdan KA, et al. The Mechanical Autophagy as a Part of Cellular Immunity; Facts and Features in Treating the Medical Disorders. Immunol Invest, 2022, 51:266–289. https://doi.org/10.1080/08820139.2020.1828453

El-Fadl HMA, Hagag NM, El-Shafei RA, et al. Effective Targeting of Raf-1 and Its Associated Autophagy by Novel Extracted Peptide for Treating Breast Cancer Cells. Front Oncol. 2021, 11:3317. https://doi.org/10.3389/fonc.2021.682596

Elimam H, El-Say KM, Cybulsky A V, Khalil H. Regulation of Autophagy Progress via Lysosomal Depletion by Fluvastatin Nanoparticle Treatment in Breast Cancer Cells. 2020. ACS Omega. https://doi.org/10.1021/acsomega.0c01618

Ahmadi-Dehlaghi F, Mohammadi P, Valipour E, et al. Autophagy: A challengeable paradox in cancer treatment. Cancer Med, 2023, 12:11542–11569. https://doi.org/https://doi.org/10.1002/cam4.5577

Grivennikov SI, Karin M. Inflammation and oncogenesis: a vicious connection. Curr Opin Genet Dev, 2010, 20:65–71. https://doi.org/10.1016/j.gde.2009.11.004

Escudero-Lourdes C, Wu T, Camarillo JM, Gandolfi AJ. Interleukin-8 (IL-8) over-production and autocrine cell activation are key factors in monomethylarsonous acid [MMA(III)]-induced malignant transformation of urothelial cells. Toxicol Appl Pharmacol, 2012, 258:10–18. https://doi.org/10.1016/j.taap.2011.10.002

Zhou Q, Jin P, Liu J, et al. HER2 overexpression triggers the IL-8 to promote arsenic-induced EMT and stem cell-like phenotypes in human bladder epithelial cells. Ecotoxicol Environ Saf, 2021, 208:111693. https://doi.org/https://doi.org/10.1016/j.ecoenv.2020.111693

Abd El Maksoud AI, Elebeedy D, Abass NH, et al. Methylomic Changes of Autophagy-Related Genes by Legionella Effector Lpg2936 in Infected Macrophages. Front Cell Dev Biol, 2020, 7:390. https://doi.org/10.3389/fcell.2019.00390

Hamouda RA, Abd El Maksoud AI, Wageed M, et al. Characterization and Anticancer Activity of Biosynthesized Au/Cellulose Nanocomposite from Chlorella vulgaris. Polymers, 2021, 13: (19) 3340. https://doi.org/10.3390/polym13193340

Mohamed E-SA, Bassiouny K, Alshambky AA, Khalil H. Anticancer Properties of N,N-dibenzylasparagine as an Asparagine (Asp) analog, Using Colon Cancer Caco-2 Cell Line. Asian Pacific J Cancer Prev, 2022, 23:2531–2540. https://doi.org/10.31557/APJCP.2022.23.7.2531

Khalil H, Abd El Maksoud AI, Roshdey T, El-Masry S. Guava flavonoid glycosides prevent influenza A virus infection via rescue of P53 activity. J Med Virol, 2019, 91:45–55. https://doi.org/10.1002/jmv.25295

Khalil H, Arfa M, El-Masrey S, et al. Single nucleotide polymorphisms of interleukins associated with hepatitis C virus infection in Egypt. J Infect Dev Ctries, 2017, 11:261–268. https://doi.org/10.3855/jidc.8127

Maher E, Gedawy G, Fathy W, et al. Hsa-miR-21-mediated cell death and tumor metastases: A potential dual response during colorectal cancer development. Middle East J Cancer, 2020, 11:483-492. https://doi.org/10.30476/mejc.2020.83146.1139

Abdelaziz DHA, Khalil H, Cormet-Boyaka E, Amer AO. The cooperation between the autophagy machinery and the inflammasome to implement an appropriate innate immune response: Do they regulate each other? Immunol. Rev, 2015, 265:194–204.

Khalil H, Elhady AA, Elawdan KA, et al. The Mechanical Autophagy as a Part of Cellular Immunity ; Facts and Features in Treating the Medical Disorders The Mechanical Autophagy as a Part of Cellular Immunity ; Facts and Features in Treating the Medical Disorders. Immunol Invest, 2020, 00:1–24. https://doi.org/doi.org/10.1080/08820139.2020.1828453.

Jiang G-M, Tan Y, Wang H, et al. The relationship between autophagy and the immune system and its applications for tumor immunotherapy. Mol Cancer, 2019, 18:17. https://doi.org/10.1186/s12943-019-0944-z

Emran T Bin, Shahriar A, Mahmud AR, et al. Multidrug Resistance in Cancer: Understanding Molecular Mechanisms, Immunoprevention and Therapeutic Approaches. Front Oncol, 2022, 12:891652. https://doi.org/10.3389/fonc.2022.891652

Xu W, Jiang X, Huang L. RNA Interference Technology. In: Comprehensive Biotechnology. 2019. Elsevier, 560–575

Madden E, Logue SE, Healy SJ, et al. The role of the unfolded protein response in cancer progression: From oncogenesis to chemoresistance. Biol Cell, 2019, 111:1–17. https://doi.org/https://doi.org/10.1111/boc.201800050

Folkerts H, Hilgendorf S, Vellenga E, et al. The multifaceted role of autophagy in cancer and the microenvironment. Med Res Rev, 2019, 39:517–560. https://doi.org/doi:10.1002/med.21531

Park JW, Kim Y, Lee S, et al. Autophagy inhibits cancer stemness in triple-negative breast cancer via miR-181a-mediated regulation of ATG5 and/or ATG2B. Mol Oncol, 2022, 16:1857–1875. https://doi.org/https://doi.org/10.1002/1878-0261.13180

Kim M-Y, Oskarsson T, Acharyya S, et al. Tumor Self-Seeding by Circulating Cancer Cells. Cell, 2009, 139:1315–1326. https://doi.org/10.1016/j.cell.2009.11.025

Grivennikov SI, Greten FR, Karin M. Immunity, inflammation, and cancer. Cell, 2010, 140:883–899.

White E, Mehnert JM, Chan CS. Autophagy, Metabolism, and Cancer. Clin Cancer Res, 2015, 21:5037–5046. https://doi.org/10.1158/1078-0432.CCR-15-0490

Brech A, Ahlquist T, Lothe RA, Stenmark H. Autophagy in tumour suppression and promotion. Mol Oncol, 2009, 3:366–375. https://doi.org/https://doi.org/10.1016/j.molonc.2009.05.007

Jung S, Jeong H, Yu S-W. Autophagy as a decisive process for cell death. Exp Mol Med, 2020, 52:921–930. https://doi.org/10.1038/s12276-020-0455-4

Published
2023-08-17
How to Cite
Alian, A., Guirgis, A. A., & Khalil, H. (2023). Regulation of Breast Cancer Cell Proliferation and Immunity via Targeting Autophagic Process Using siRNA Antagonist Atg-5 in MCF-7 Cells.: Targeting autophagy in breast cancer . Journal of Internal Medicine: Science & Art, 4, 26 - 32. https://doi.org/10.36013/jimsa.v4i.117
Section
Articles